179 related articles for article (PubMed ID: 9105692)
1. The ability of a new hypoglycaemic agent, A-4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic beta-cells under metabolic inhibition.
Fujitani S; Okazaki K; Yada T
Br J Pharmacol; 1997 Apr; 120(7):1191-8. PubMed ID: 9105692
[TBL] [Abstract][Full Text] [Related]
2. A novel D-phenylalanine-derivative hypoglycemic agent A-4166 increases cytosolic free Ca2+ in rat pancreatic beta-cells by stimulating Ca2+ influx.
Fujitani S; Yada T
Endocrinology; 1994 Mar; 134(3):1395-400. PubMed ID: 8119179
[TBL] [Abstract][Full Text] [Related]
3. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
Hashiguchi S; Yada T; Arima T
J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
[TBL] [Abstract][Full Text] [Related]
4. Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride.
Müller G; Korndörfer A; Kornak U; Malaisse WJ
Arch Biochem Biophys; 1994 Jan; 308(1):8-23. PubMed ID: 8311478
[TBL] [Abstract][Full Text] [Related]
5. Glucose and tolbutamide trigger transients of Ca2+ in single pancreatic beta-cells exposed to tetraethylammonium.
Eberhardson M; Grapengiesser E
Cell Calcium; 1999 May; 25(5):355-60. PubMed ID: 10463099
[TBL] [Abstract][Full Text] [Related]
6. Glucose metabolism by rat pancreatic beta-cells produces dual change in cytosolic Ca2+.
Yada T; Itoh K; Kakei M; Tanaka H
Jpn J Physiol; 1993; 43 Suppl 1():S115-8. PubMed ID: 8271483
[TBL] [Abstract][Full Text] [Related]
7. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC
Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166).
Ikenoue T; Akiyoshi M; Fujitani S; Okazaki K; Kondo N; Maki T
Br J Pharmacol; 1997 Jan; 120(1):137-45. PubMed ID: 9117089
[TBL] [Abstract][Full Text] [Related]
9. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells.
Best L; Benington S
Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927
[TBL] [Abstract][Full Text] [Related]
10. Sulfonylurea mimics the effect of glucose in inducing large amplitude oscillations of cytoplasmic Ca2+ in pancreatic beta-cells.
Grapengiesser E; Gylfe E; Hellman B
Mol Pharmacol; 1990 Mar; 37(3):461-7. PubMed ID: 2179710
[TBL] [Abstract][Full Text] [Related]
11. Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria.
Grimmsmann T; Rustenbeck I
Br J Pharmacol; 1998 Mar; 123(5):781-8. PubMed ID: 9535004
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas.
Fujitani S; Ikenoue T; Akiyoshi M; Maki T; Yada T
Metabolism; 1996 Feb; 45(2):184-9. PubMed ID: 8596487
[TBL] [Abstract][Full Text] [Related]
13. cAMP-signaling pathway acts in selective synergism with glucose or tolbutamide to increase cytosolic Ca2+ in rat pancreatic beta-cells.
Yaekura K; Kakei M; Yada T
Diabetes; 1996 Mar; 45(3):295-301. PubMed ID: 8593933
[TBL] [Abstract][Full Text] [Related]
14. Repetitive mitochondrial Ca2+ signals synchronize with cytosolic Ca2+ oscillations in the pancreatic beta-cell line, MIN6.
Nakazaki M; Ishihara H; Kakei M; Inukai K; Asano T; Miyazaki JI; Tanaka H; Kikuchi M; Yada T; Oka Y
Diabetologia; 1998 Mar; 41(3):279-86. PubMed ID: 9541167
[TBL] [Abstract][Full Text] [Related]
15. Does glucose decrease cytosolic free calcium in normal pancreatic islet cells?
Gobbe P; Herchuelz A
Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):231-47. PubMed ID: 2652230
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mitochondrial function affects cellular Ca2+ handling in pancreatic B-cells.
Düfer M; Krippeit-Drews P; Drews G
Pflugers Arch; 2002 May; 444(1-2):236-43. PubMed ID: 11976937
[TBL] [Abstract][Full Text] [Related]
17. A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic beta-cells.
Akiyoshi M; Kakei M; Nakazaki M; Tanaka H
Am J Physiol; 1995 Feb; 268(2 Pt 1):E185-93. PubMed ID: 7864093
[TBL] [Abstract][Full Text] [Related]
18. Effects of gliquidone on D-glucose metabolism in rat pancreatic islets depend on hexose concentration.
Picton S; Malaisse-Lagae F; Malaisse WJ
Res Commun Mol Pathol Pharmacol; 1998 Nov; 102(2):99-112. PubMed ID: 10100502
[TBL] [Abstract][Full Text] [Related]
19. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
[TBL] [Abstract][Full Text] [Related]
20. Effects of tolbutamide and N-benzoyl-D-phenylalanine (NBDP) on the regulation of [Ca2+]i oscillations in mouse pancreatic islets.
Lenzen S; Peckmann T
Biochem Pharmacol; 2001 Oct; 62(7):923-8. PubMed ID: 11543727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
